KYMR
Price
$50.87
Change
-$0.14 (-0.27%)
Updated
Sep 23 closing price
Capitalization
3.64B
36 days until earnings call
NUVL
Price
$81.14
Change
+$2.24 (+2.84%)
Updated
Sep 23, 04:59 PM (EDT)
Capitalization
5.69B
44 days until earnings call
Interact to see
Advertisement

KYMR vs NUVL

Header iconKYMR vs NUVL Comparison
Open Charts KYMR vs NUVLBanner chart's image
Kymera Therapeutics
Price$50.87
Change-$0.14 (-0.27%)
Volume$482.99K
Capitalization3.64B
Nuvalent
Price$81.14
Change+$2.24 (+2.84%)
Volume$4.47K
Capitalization5.69B
KYMR vs NUVL Comparison Chart in %
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. NUVL commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Buy and NUVL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (KYMR: $51.01 vs. NUVL: $78.90)
Brand notoriety: KYMR and NUVL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 103% vs. NUVL: 74%
Market capitalization -- KYMR: $3.64B vs. NUVL: $5.69B
KYMR [@Biotechnology] is valued at $3.64B. NUVL’s [@Biotechnology] market capitalization is $5.69B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileNUVL’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • NUVL’s FA Score: 0 green, 5 red.
According to our system of comparison, NUVL is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 6 TA indicator(s) are bullish while NUVL’s TA Score has 5 bullish TA indicator(s).

  • KYMR’s TA Score: 6 bullish, 4 bearish.
  • NUVL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than NUVL.

Price Growth

KYMR (@Biotechnology) experienced а +7.89% price change this week, while NUVL (@Biotechnology) price change was -0.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.94%. For the same industry, the average monthly price growth was +8.31%, and the average quarterly price growth was +48.45%.

Reported Earning Dates

KYMR is expected to report earnings on Oct 30, 2025.

NUVL is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVL($5.69B) has a higher market cap than KYMR($3.64B). KYMR YTD gains are higher at: 26.448 vs. NUVL (0.792). KYMR has higher annual earnings (EBITDA): -267.03M vs. NUVL (-362.01M). NUVL has more cash in the bank: 1.01B vs. KYMR (665M). KYMR has higher revenues than NUVL: KYMR (44.7M) vs NUVL (0).
KYMRNUVLKYMR / NUVL
Capitalization3.64B5.69B64%
EBITDA-267.03M-362.01M74%
Gain YTD26.4480.7923,339%
P/E RatioN/AN/A-
Revenue44.7M0-
Total Cash665M1.01B66%
Total Debt85.7MN/A-
TECHNICAL ANALYSIS
Technical Analysis
KYMRNUVL
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 22 days ago
88%
Bearish Trend 8 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HRSRX86.111.65
+1.95%
Hood River Small-Cap Growth Investor
POIIX16.180.03
+0.19%
Polen International Growth Institutional
MIQBX12.08N/A
N/A
Morgan Stanley Inst International Eq A
FCNKX25.11N/A
N/A
Fidelity Contrafund K
MMCGX29.46N/A
N/A
Morgan Stanley Inst Discovery R6

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been closely correlated with NRIX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-0.27%
NRIX - KYMR
67%
Closely correlated
-2.25%
VERA - KYMR
59%
Loosely correlated
-0.57%
CGON - KYMR
56%
Loosely correlated
-0.92%
RGNX - KYMR
53%
Loosely correlated
-1.43%
XNCR - KYMR
52%
Loosely correlated
-0.67%
More

NUVL and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVL has been loosely correlated with CGON. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVL jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVL
1D Price
Change %
NUVL100%
+2.91%
CGON - NUVL
54%
Loosely correlated
+0.38%
NRIX - NUVL
51%
Loosely correlated
-0.12%
RVMD - NUVL
51%
Loosely correlated
+2.00%
KYMR - NUVL
50%
Loosely correlated
+3.83%
CRNX - NUVL
50%
Loosely correlated
-0.56%
More